Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-α treatment

Andreas Hochhaus, Brian Druker, Charles Sawyers, Francois Guilhot, Charles A. Schiffer, Jorge Cortes, Dietger W. Niederwieser, Carlo Gambacorti-Passerini, Richard M. Stone, John Goldman, Thomas Fischer, Stephen G. O'Brien, Jose J. Reiffers, Manisha Mone, Tillmann Krahnke, Moshe Talpaz, Hagop M. Kantarjian

Blood (2008) 111 (3): 1039–1043.

https://doi.org/10.1182/blood-2007-07-103523

Published: 2008

Journal Articles

First Line Therapy with Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Patients with Acute Myeloblastic Leukemia in First Complete Remission.

Didier Blaise, J.M. Boiron, C. Faucher, M. Mohty, J.O. Bay, K. Bilger, G. Marit, V.J. Bardoux, V. Perreau, D. Coso, A.M. Stoppa, J.A. Gastaut, J. Reiffers, D. Maraninchi, N. Vey

Blood (2004) 104 (11): 101.

https://doi.org/10.1182/blood.V104.11.101.101

Published: 2004

Journal Articles

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study: Presented in part at the 43rd Annual Meeting of The American Society of Hematology, Orlando, FL, December 11, 2001.

Blood (2002) 99 (10): 3530–3539.

https://doi.org/10.1182/blood.V99.10.3530

Published: 2002

Journal Articles

Response at Three Months Is a Good Predictive Factor for Newly Diagnosed Chronic Myeloid Leukemia Patients Treated by Recombinant Interferon-: Presented in part at the 38th annual meeting of the American Society of Hematology, Orlando, FL, December 6-10, 1996.

F.X. Mahon, C. Fabères, S. Pueyo, P. Cony-Makhoul, R. Salmi, J.M. Boiron, G. Marit, C. Bilhou-Nabera, A. Carrère, M. Montastruc, A. Pigneux, Ph. Bernard, J. Reiffers

Blood (1998) 92 (11): 4059–4065.

https://doi.org/10.1182/blood.V92.11.4059

Published: 1998

Journal Articles

Karyotype in Acute Myeloblastic Leukemia: Prognostic Significance for Bone Marrow Transplantation in First Remission: A European Group for Blood and Marrow Transplantation Study

A. Ferrant, M. Labopin, F. Frassoni, H.G. Prentice, J.Y. Cahn, D. Blaise, J. Reiffers, G. Visani, M.A. Sanz, M.A. Boogaerts, B. Löwenberg, N.C. Gorin

Blood (1997) 90 (8): 2931–2938.

https://doi.org/10.1182/blood.V90.8.2931

Published: 1997

Journal Articles

Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Societe Francaise de Greffe de Moelle

Blood (1996) 88 (1): 358–365.

https://doi.org/10.1182/blood.V88.1.358.358

Published: 1996

Journal Articles

In vitro biosynthesis of leukemia inhibitory factor/human interleukin for DA cells by human endothelial cells: differential regulation by interleukin-1 alpha and glucocorticoids

C Grosset, B Jazwiec, JL Taupin, H Liu, S Richard, FX Mahon, J Reiffers, JF Moreau, J Ripoche

Blood (1995) 86 (10): 3763–3770.

https://doi.org/10.1182/blood.V86.10.3763.bloodjournal86103763

Published: 1995

Journal Articles

Autologous bone marrow transplantation for first remission acute myeloblastic leukemia in patients older than 50 years: a retrospective analysis of the European Bone Marrow Transplant Group

JY Cahn, M Labopin, F Mandelli, AH Goldstone, K Eberhardt, J Reiffers, A Ferrant, I Franklin, P Herve, A Gratwohl

Blood (1995) 85 (2): 575–579.

https://doi.org/10.1182/blood.V85.2.575.575

Published: 1995

Journal Articles

A controlled trial of recombinant human erythropoietin after bone marrow transplantation

H Link, MA Boogaerts, AA Fauser, S Slavin, J Reiffers, NC Gorin, AM Carella, F Mandelli, S Burdach, A Ferrant

Blood (1994) 84 (10): 3327–3335.

https://doi.org/10.1182/blood.V84.10.3327.3327

Published: 1994

Journal Articles

Predicting complete cytogenetic response in chronic myelogenous leukemia patients treated with recombinant interferon alpha [letter; comment]

FX Mahon, M Montastruc, C Faberes, J Reiffers

Blood (1994) 84 (10): 3592–3594.

https://doi.org/10.1182/blood.V84.10.3592a.3592a

Published: 1994

Journal Articles

Detection of cytarabine resistance in patients with acute myelogenous leukemia using flow cytometry

F Lacombe, F Belloc, P Dumain, M Puntous, PC Makhoul, MC Saux, P Bernard, MR Boisseau, J Reiffers

Blood (1994) 84 (3): 716–723.

https://doi.org/10.1182/blood.V84.3.716.716

Published: 1994

Journal Articles

Multicenter randomized study comparing cyclosporine-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia

E Gluckman, H Esperou-Bourdeau, A Baruchel, M Boogaerts, J Briere, D Donadio, G Leverger, M Leporrier, J Reiffers, M Janvier

Blood (1992) 79 (10): 2540–2546.

https://doi.org/10.1182/blood.V79.10.2540.2540

Published: 1992

Journal Articles

Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse [see comments]

D Blaise, D Maraninchi, E Archimbaud, J Reiffers, A Devergie, JP Jouet, N Milpied, M Attal, M Michallet, N Ifrah

Blood (1992) 79 (10): 2578–2582.

https://doi.org/10.1182/blood.V79.10.2578.2578

Published: 1992

Journal Articles

High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse

D Maraninchi, D Blaise, P Viens, M Brandely, D Olive, M Lopez, D Sainty, G Marit, AM Stoppa, J Reiffers

Blood (1991) 78 (9): 2182–2187.

https://doi.org/10.1182/blood.V78.9.2182.2182

Published: 1991

Journal Articles

Long-term marrow cultures after allogeneic bone marrow transplantation [letter; comment]

A Rice, J Reiffers, P Bernard, C Foures, F Lacombe, G Marit, A Broustet

Blood (1990) 76 (1): 266–267.

https://doi.org/10.1182/blood.V76.1.266.266

Published: 1990

Journal Articles

Bone marrow transplantation in multiple myeloma: report from the European Cooperative Group for Bone Marrow Transplantation

G Gahrton, S Tura, M Flesch, A Gratwohl, P Gravett, G Lucarelli, M Michallet, J Reiffers, O Ringden, MT van Lint

Blood (1987) 69 (4): 1262–1264.

https://doi.org/10.1182/blood.V69.4.1262.1262

Published: 1987

Journal Articles

Acute myeloid leukemia with marrow hypereosinophilia and chromosome 16 [letter]

P Bernard, D Dachary, F Lacombe, MR Boisseau, B David, J Reiffers, A Broustet

Blood (1984) 63 (1): 243.

https://doi.org/10.1182/blood.V63.1.243a.243a

Published: 1984

NARROW

Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-α treatment

First Line Therapy with Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Patients with Acute Myeloblastic Leukemia in First Complete Remission.

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study: Presented in part at the 43rd Annual Meeting of The American Society of Hematology, Orlando, FL, December 11, 2001.

Response at Three Months Is a Good Predictive Factor for Newly Diagnosed Chronic Myeloid Leukemia Patients Treated by Recombinant Interferon-: Presented in part at the 38th annual meeting of the American Society of Hematology, Orlando, FL, December 6-10, 1996.

Karyotype in Acute Myeloblastic Leukemia: Prognostic Significance for Bone Marrow Transplantation in First Remission: A European Group for Blood and Marrow Transplantation Study

Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Societe Francaise de Greffe de Moelle

In vitro biosynthesis of leukemia inhibitory factor/human interleukin for DA cells by human endothelial cells: differential regulation by interleukin-1 alpha and glucocorticoids

Autologous bone marrow transplantation for first remission acute myeloblastic leukemia in patients older than 50 years: a retrospective analysis of the European Bone Marrow Transplant Group

A controlled trial of recombinant human erythropoietin after bone marrow transplantation

Predicting complete cytogenetic response in chronic myelogenous leukemia patients treated with recombinant interferon alpha [letter; comment]

Detection of cytarabine resistance in patients with acute myelogenous leukemia using flow cytometry

Multicenter randomized study comparing cyclosporine-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia

Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse [see comments]

High-dose recombinant interleukin-2 and acute myeloid leukemias in relapse

Long-term marrow cultures after allogeneic bone marrow transplantation [letter; comment]

Bone marrow transplantation in multiple myeloma: report from the European Cooperative Group for Bone Marrow Transplantation

Acute myeloid leukemia with marrow hypereosinophilia and chromosome 16 [letter]

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only